A 32-year-old woman presents with a 3-day history of painful vesicles in a dermatomal distribution on the right chest wall. She reports severe pain and burning sensation. Examination reveals clustered vesicles on an erythematous base following the T5 dermatome. She has no immunosuppression and normal vital signs. What is the most appropriate immediate management?

Explanation

## Clinical Presentation Analysis This patient presents with classic **herpes zoster (shingles)** in an immunocompetent host: - Dermatomal distribution (T5 dermatome) - Vesicles on erythematous base - Severe pain and burning (neuropathic) - Early presentation (3 days — within the treatment window) ## Management Strategy ### Key Point: **Antiviral therapy must be initiated within 72 hours of rash onset** to reduce duration of acute pain, prevent dissemination, and reduce post-herpetic neuralgia (PHN) risk. ### High-Yield: In **immunocompetent patients with localized zoster**, oral acyclovir 800 mg five times daily for 7–10 days is the standard first-line agent. This dose is specifically chosen for zoster (higher than for HSV). ## Dosing Regimen | Agent | Dose (Immunocompetent) | Duration | Notes | |-------|------------------------|----------|-------| | **Acyclovir (oral)** | 800 mg 5× daily | 7–10 days | First-line; requires frequent dosing | | **Valacyclovir (oral)** | 1000 mg 3× daily | 7 days | Better bioavailability; preferred if available | | **Famciclovir (oral)** | 500 mg 3× daily | 7 days | Longest intracellular half-life | ### Clinical Pearl: Early antiviral therapy (within 72 hours) reduces: - Duration of acute pain by ~1 week - Incidence of PHN in patients >50 years by ~50% - Risk of dissemination and visceral involvement ## Adjunctive Management 1. **Analgesics**: Paracetamol, NSAIDs, or gabapentin for neuropathic pain 2. **Topical care**: Calamine lotion, cool compresses (do NOT use occlusive dressings) 3. **Secondary infection prevention**: Keep lesions clean and dry ### Warning: Do NOT delay antiviral therapy awaiting confirmatory testing in a clinically obvious case — the 72-hour window is critical.